Sold Out
Co-lyophilised blend of GHK-Cu, BPC-157 and TB-500. For in-vitro laboratory research use only.
£59.99
Out of stockTirzepatide
Out of stock
- Dual agonist
- GIP / GLP-1
- CAS 2023788-19-2
- ≥ 99.0% (RP-HPLC)
- Lyophilised powder, batch COA supplied
- Available in 30mg and 60mg vials
Dual GIP and GLP-1 receptor agonist peptide. Supplied lyophilised for in-vitro metabolic research.
Every UK order includes
- 99.0% HPLC purity, independently verified
- Batch documentation / COA with every order
- Priority shipping — UK & EU · international available
- Discreet, temperature-controlled packaging
Secure Checkout
-
-
-
Wallid
-
Bank transfer
-
BTC
-
ETH
-
USDT
Free priority shipping
On all UK orders — discreet and tracked.
Worldwide shipping
We ship across the EU & internationally, tracked to your door.
24-hour processing
Orders placed before 12pm GMT ship the same day from our UK hub.
Delivery guarantee
Lost or damaged? We reship — no questions. Order with confidence.
Analytical data
Specifications,
verified.
Specifications for this compound, independently verified by HPLC and LC-MS before release.
| Property | Tirzepatide |
|---|---|
| Full name | Tirzepatide (LY3298176) |
| CAS number | 2023788-19-2 |
| Molecular formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular weight | 4813.53 g/mol |
| Purity (HPLC) | ≥ 99.0% (RP-HPLC) |
| Mass confirmation | Confirmed by LC-MS |
| Residual moisture | ≤ 5.0% (Karl Fischer) |
| Form | Lyophilised powder |
| Solubility | Bacteriostatic or sterile water |
| Storage | −20°C sealed and protected from light; 2–8°C once reconstituted |
| Half-life | Approximately 5 days, per published pharmacokinetic studies |
About this peptide
Tirzepatide
Tirzepatide is supplied as a laboratory research material for qualified analytical and in-vitro research environments.
-
01 Dual incretin agonist
A single 39-residue chain with activity at both the GIP and GLP-1 receptors — the design that earned it the "twincretin" label.
-
02 C20 fatty-diacid conjugate
Acylation at Lys20 drives albumin binding, which is what extends the reported half-life to roughly five days.
-
03 Published record
The SURPASS phase 3 programme reported in The New England Journal of Medicine and The Lancet, 2021–2022.
-
04 Research material
Supplied lyophilised at −20°C with a batch certificate of analysis, for analytical and in-vitro use only.
FAQ
Before you order.
Anything not covered here, ask us directly — replies within one working day.
Is a COA included with my order?
Yes. Every vial ships with a certificate of analysis tied to the lot number printed on its label, covering identity by mass spectrometry and purity by HPLC. Retained samples are held so a batch can be re-tested.
How is the product shipped?
Lyophilised powder is stable at ambient temperature in transit and ships in discreet, tracked packaging. UK and EU orders are sent on a priority service; international destinations are quoted at checkout.
How should the vial be stored on arrival?
Keep it sealed at −20°C, protected from light. Lyophilised material is stable for months under those conditions. Once reconstituted, store at 2–8°C and use within the window stated on the certificate of analysis.
Who is this product for?
Qualified researchers and laboratories only. It is supplied strictly as an analytical and in-vitro research material, and is not a medicine, a supplement or a veterinary product.
What is the difference between the 30 mg and 60 mg vials?
Only the quantity of lyophilised peptide in the vial. Both are the same compound from the same specification, and both ship with their own certificate of analysis.
More from the catalogue
Related compounds
Sold Out
Synthetic tetrapeptide (Ala-Glu-Asp-Gly). Supplied lyophilised for in-vitro cellular research.
£19.99
Out of stock
Triple GIP, GLP-1 and glucagon receptor agonist. Lyophilised powder for in-vitro metabolic research.
Price range: £30.99 through £114.99
Add to cart
Add to cart
